Studies showed that GSI treatment induces G0/G1 arrest along with rapid clearance of intracellular NOTCH1. However, the clinical development of GSIs has been hindered by their low cytotoxicity against human T-ALL and GIT toxicity derived from inhibition of NOTCH signaling in the gut [38]. Here, NOTCH1 is linked to acute lymphoblastic leukemia.